Clinical Trial Update: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Indocyanine Green to Blue Dye for detecting sentinel lymph nodes in endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Neoplasms

Drugs mentioned

• Blue dye (blue dye)
• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Endometrial Neoplasms | Phase 3 | Status: COMPLETED